Cell cycle perturbation and acquired 5-fluorouracil chemoresistance

Area of Science:

• Cancer Research
• Molecular Biology
• Cell Cycle Regulation

Background:

• Acquired chemoresistance to 5-fluorouracil (5-FU) hinders effective cancer chemotherapy.
• The molecular mechanisms underlying 5-FU resistance are not fully understood.
• Previous studies indicated down-regulation of cell cycle genes in resistant cell lines.

Purpose of the Study:

• To investigate the role of cell cycle alterations in acquired 5-FU resistance.
• To compare cell cycle kinetics and protein expression in 5-FU resistant and sensitive cancer cell lines.
• To elucidate potential mechanisms by which cell cycle perturbation contributes to 5-FU resistance.

Main Methods:

• Flow cytometry analysis of propidium iodide and BrdU incorporation to assess cell cycle distribution.
• Western blot analysis to determine protein expression levels of cell cycle regulators (CDK2, Cyclins, pRB).
• Comparison of acquired 5-FU resistant (H630R10, T47DFU2.5) and parental cancer cell lines.

Main Results:

• Resistant cell lines exhibited cell cycle delays in G1 and G1/S phases and prolonged DNA synthesis.
• Both resistant cell lines showed significantly prolonged potential doubling times (Tpot).
• Reduced expression of CDK2, Cyclin D3, and Cyclin A was observed in resistant cells.
• Hypophosphorylation of pRB was detected in resistant cancer cells, indicating altered cell cycle control.

Conclusions:

• Cell cycle perturbation, characterized by a slowdown in traverse, is implicated in acquired 5-FU resistance.
• This slow down may impede 5-FU metabolite incorporation into DNA and allow for nucleotide repair.
• Targeting cell cycle regulation could be a strategy to overcome 5-FU resistance in cancer.